Related Experiment Videos
Seminal changes in the management of the acute coronary event: current concepts
Laurie G Futterman1, Louis Lemberg
1Division of Cardiology, Department of Medicine, University of Miami School of Medicine, Miami, Fla., USA.
Insights
Atherosclerosis complications are now linked to plaque inflammation, not just size. Statins and other treatments effectively manage coronary artery disease (CAD), preventing heart attacks.
Area of Science:
- Cardiovascular Medicine
- Atherosclerosis Research
Background:
- Traditionally, high-grade arterial stenosis was considered the primary cause of acute atherosclerosis complications.
- Current research is reassessing the role of plaque characteristics in cardiovascular events.
Observation:
- Qualitative plaque features, such as inflammation, are now recognized as more critical than quantitative measures like plaque size.
- Statins offer numerous cardiovascular benefits, including lipid reduction, plaque stabilization, and anti-inflammatory effects.
Findings:
- Statins demonstrate pleiotropic effects: lipid lowering, plaque stabilization, improved endothelial function, and antiatherothrombotic activities.
- Comprehensive management of coronary artery disease (CAD) involves statins, beta-blockers, ACE inhibitors, aspirin, blood pressure control, diet, and exercise.
Implications:
- Understanding plaque qualitative aspects shifts focus from stenosis severity to plaque vulnerability in atherosclerosis.
- Integrated medical management strategies have proven successful in preventing acute cardiovascular events and myocardial infarctions.
Abstract:
In the past era, we held high-grade arterial stenosis responsible for the acute complications of atherosclerosis. These concepts are being reassessed. Qualitative rather than quantitative aspects of plaques (e.g., inflammation rather than plaque size) have been established as decisive determinants of their probabilities to cause acute complications. Numerous beneficial effects of statins have been demonstrated. These include lipid lowering, plaque stability, enhanced endothelial function, and antiplatelet, antiatherothrombotic, and antimacrophage activities. However, the successful medical management of CAD is also multifactorial and in addition to use of statins include beta-blockers, ACE inhibitors, and aspirin, as well as blood pressure control, diet, and exercise (see [figure: see text] Figure). The results have been not only the preventions of acute complications of atherosclerosis, but also the successes in stabilizing acute coronary events and preventing infarctions.